Roche's Strategic Expansion in the US

In a bold move to bolster its presence in the United States, F. Hoffmann-La Roche AG has unveiled plans to inject $50 billion into the country's pharmaceutical sector over the next five years. This significant investment aims to enhance manufacturing capabilities and establish new facilities across key states including Indiana, Pennsylvania, Massachusetts, and California.

Creating Jobs and Strengthening Commitments

As part of this expansive initiative, Roche is set to increase its workforce by more than 12,000 employees, marking a substantial boost to the local economies of the involved states. "Our investment reflects Roche's unwavering dedication to innovation and excellence in the US," stated Roche Group CEO Thomas Schinecker, highlighting the company's global heritage and commitment to research and development.